IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,460 | -35.4% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8,448 | +15.2% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $7,332 | -4.4% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $7,668 | -30.3% | 1,200 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $11,000 | -15.4% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $13,000 | -35.0% | 1,200 | -14.3% | 0.00% | -33.3% |
| Q1 2022 | $20,000 | 0.0% | 1,400 | +75.0% | 0.00% | -25.0% |
| Q3 2021 | $20,000 | -4.8% | 800 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $21,000 | -16.0% | 800 | 0.0% | 0.01% | -28.6% |
| Q1 2021 | $25,000 | -32.4% | 800 | 0.0% | 0.01% | -46.2% |
| Q4 2020 | $37,000 | +42.3% | 800 | 0.0% | 0.01% | +18.2% |
| Q3 2020 | $26,000 | – | 800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |